Attached files

file filename
8-K - 8-K - Surgical Care Affiliates, Inc.d653924d8k.htm

Exhibit 99.1

Surgical Care Affiliates, Inc.

Unaudited Pro Forma Condensed Consolidated Financial Statements

On December 31, 2013, a wholly owned subsidiary of Surgical Care Affiliates, Inc. (“SCA”) sold its controlling 51% equity interest in Fort Worth Endoscopy Center (“FWEC”) for $1.3 million in cash consideration.

The following unaudited pro forma condensed consolidated balance sheet of SCA as of September 30, 2013 and unaudited pro forma condensed consolidated statements of operations of SCA for the nine–month period ended September 30, 2013 and the year ended December 31, 2012, give effect to this sale. The unaudited pro forma condensed consolidated financial statements have been prepared by management of SCA based upon the historical financial statements of SCA and the adjustments and assumptions in the accompanying notes to the pro forma condensed consolidated financial statements.

The unaudited pro forma condensed consolidated balance sheet reflects the disposition of FWEC as if such a transaction had been consummated on September 30, 2013.

The unaudited pro forma condensed consolidated statements of operations set forth the effect of the disposition of FWEC as if it had occurred on January 1, 2012.

The unaudited pro forma condensed consolidated financial statements may not be indicative of the results that actually would have occurred if the sale of FWEC had occurred on the dates indicated or which may be obtained in the future. The unaudited pro forma condensed consolidated financial statements should be read in conjunction with (i) SCA’s historical audited consolidated financial statements and related notes thereto as of and for the year ended December 31, 2012 contained in its prospectus dated October 29, 2013, which was filed with the Securities and Exchange Commission (the “SEC”) on October 30, 2013 as part of SCA’s registration statement on Form S-1, as amended, which was declared effective by the SEC on October 29, 2013, and (ii) SCA’s historical unaudited condensed consolidated financial statements and related notes thereto as of and for the nine-months ended September 30, 2013 contained in its Quarterly Report on Form 10-Q filed with the SEC on November 15, 2013.

Certain amounts in the unaudited pro forma condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation.

SCA was converted from a Delaware limited liability company, previously named ASC Acquisition LLC, to a Delaware corporation on October 30, 2013. Pursuant to the conversion, every 10.25 outstanding membership units of ASC Acquisition LLC were converted into one share of common stock of SCA, and options to purchase membership units of ASC Acquisition LLC were converted into options to purchase shares of common stock of SCA at a ratio of 10.25 membership units of ASC Acquisition LLC underlying such options to each one share of common stock of SCA underlying such converted options. In connection with the conversion, the exercise prices of such converted options were adjusted accordingly. In addition, every 10.25 outstanding restricted equity units of ASC Acquisition LLC were converted into one restricted share of SCA. The unaudited pro forma condensed consolidated financial statements reflect the conversion to a Delaware corporation.


SURGICAL CARE AFFILIATES, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

September 30, 2013

(In thousands of U.S. dollars)

 

     As reported      Pro forma
adjustments
    Pro forma  
Assets        

Current assets

       

Cash and cash equivalents

   $ 88,561       $ (401 )(a), (b)    $ 88,160   

Restricted cash

     21,619         —          21,619   

Accounts receivable, net of allowance for doubtful accounts (SCAI: $8,336; Pro forma: $8,328)

     81,235         (713 )(b)      80,522   

Receivable from nonconsolidated affiliates

     14,369         —          14,369   

Prepaids and other current assets

     22,203         (66 )(b)      22,137   

Current assets related to discontinued operations

     312         —          312   
  

 

 

    

 

 

   

 

 

 

Total current assets

     228,299         (1,180     227,119   

Property and equipment, net of accumulated depreciation

     183,687         (916 )(b)      182,771   

Goodwill

     701,971         (10,062 )(b)      691,909   

Intangible assets, net of accumulated amortization

Deferred debt issue costs

    

 

50,926

10,838

  

  

    

 

—  

—  

  

  

   

 

50,926

10,838

  

  

Investment in and advances to nonconsolidated affiliates

     180,618         —          180,618   

Other long-term assets

     4,536         —          4,536   

Assets related to discontinued operations

     2,128         —          2,128   
  

 

 

    

 

 

   

 

 

 

Total assets

   $ 1,363,003       $ (12,158   $ 1,350,845   
  

 

 

    

 

 

   

 

 

 
Liabilities and Equity        

Current liabilities

       

Current portion of long-term debt

   $ 21,711       $ —        $ 21,711   

Accounts payable

     22,911         (73 )(b)      22,838   

Accrued payroll

     30,432         (207 )(b)      30,225   

Accrued interest

     3,595         —          3,595   

Accrued distributions

     24,565         —          24,565   

Payable to nonconsolidated affiliates

     65,085         —          65,085   

Deferred income tax liability

     639         —          639   

Other current liabilities

     18,563         (86 )(b)      18,477   

Current liabilities related to discontinued operations

     298         —          298   
  

 

 

    

 

 

   

 

 

 

Total current liabilities

     187,799         (366     187,433   

Long-term debt, net of current portion

     789,202         (85 )(b)      789,117   

Deferred income tax liability

     110,975         —          110,975   

Other long-term liabilities

     23,111         —          23,111   

Liabilities related to discontinued operations

     403         —          403   
  

 

 

    

 

 

   

 

 

 

Total liabilities

     1,111,490         (451     1,111,039   
  

 

 

    

 

 

   

 

 

 

Noncontrolling interests – redeemable

     22,723         —          22,723   
  

 

 

    

 

 

   

 

 

 

Equity

       

Surgical Care Affiliates’ equity

     56,600         (10,068 )(b), (c)      46,532   

Noncontrolling interests – non-redeemable

     172,190         (1,639 )(b)      170,551   
  

 

 

    

 

 

   

 

 

 

Total equity

     228,790         (11,707     217,083   
  

 

 

    

 

 

   

 

 

 

Total liabilities and equity

   $ 1,363,003       $ (12,158   $ 1,350,845   
  

 

 

    

 

 

   

 

 

 

 

a) To recognize the proceeds of $1.3 million in cash from the disposition.
b) To record the removal of the net assets allocated to Fort Worth Endoscopy Center.
c) To record the estimated loss on disposition. The actual loss to be reported in continuing operations for the fourth quarter of 2013 is subject to change pending final determination of the net assets of the business, transaction costs and other adjustments.


SURGICAL CARE AFFILIATES, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the nine-months ended September 30, 2013

(In thousands of U. S. dollars except per share data)

 

     As reported     Pro forma
adjustments
(a)
    Pro forma  

Net operating revenues:

      

Net patient revenues

   $ 548,685      $ (8,167   $ 540,518   

Management fee revenues

     26,220        —         26,220   

Other revenues

     10,580        (1     10,579   
  

 

 

   

 

 

   

 

 

 

Total net operating revenues

     585,485        (8,168     577,317   

Equity in net income of nonconsolidated affiliates

     16,111        —         16,111   

Operating expenses:

      

Salaries and benefits

     202,189        (2,330     199,859   

Supplies

     128,242        (552     127,690   

Other operating expenses

     89,293        (737     88,556   

Depreciation and amortization

     31,928        (218     31,710   

Occupancy costs

     20,378        (490     19,888   

Provision for doubtful accounts

     10,364        (109     10,255   

Impairment of intangible and long-lived assets

     —         —         —    

Loss (gain) on disposal of assets

     339        —         339   
  

 

 

   

 

 

   

 

 

 

Total operating expenses

     482,733        (4,436     478,297   
  

 

 

   

 

 

   

 

 

 

Operating income

     118,863        (3,732     115,131   

Interest expense

     48,817        —         48,817   

Loss from extinguishment of debt

     3,800        —         3,800   

Interest income

     (167     3        (164

Loss on sale of investments

     1,060        —         1,060   
  

 

 

   

 

 

   

 

 

 

Income from continuing operations before income tax expense

     65,353        (3,735     61,618   

Provision for income tax expense

     10,163        (48     10,115   
  

 

 

   

 

 

   

 

 

 

Income from continuing operations

     55,190        (3,687     51,503   
  

 

 

   

 

 

   

 

 

 

Less: Net income attributable to noncontrolling interests from continuing operations

     (75,309     1,807        (73,502
  

 

 

   

 

 

   

 

 

 

Loss attributable to Surgical Care Affiliates from continuing operations

   $ (20,119   $ (1,880   $ (21,999
  

 

 

   

 

 

   

 

 

 

Basic and diluted loss per share attributable to Surgical Care Affiliates:

      

Continuing operations per share attributable to Surgical Care Affiliates

   $ (.67   $ (.06   $ (.73
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding (in thousands)

     30,347        30,347        30,347   
  

 

 

   

 

 

   

 

 

 

 

a) These Pro forma adjustments reflect the elimination of the operating results of Fort Worth Endoscopy Center assuming the transaction occurred January 1, 2012.


SURGICAL CARE AFFILIATES, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the year ended December 31, 2012

(In thousands of U. S. dollars except per share data)

 

     As reported
(a)
    Pro forma
adjustments
(b)
    Pro forma  

Net operating revenues:

      

Net patient revenues

   $ 716,191      $ (11,284   $ 704,907   

Management fee revenues

     17,804        —         17,804   

Other revenues

     12,459        (26     12,433   
  

 

 

   

 

 

   

 

 

 

Total net operating revenues

     746,454        (11,310     735,144   

Equity in net income of nonconsolidated affiliates

     16,767        —         16,767   

Operating expenses:

      

Salaries and benefits

     242,744        (3,095     239,649   

Supplies

     170,278        (803     169,475   

Other operating expenses

     118,720        (960     117,760   

Depreciation and amortization

     41,661        (320     41,341   

Occupancy costs

     26,757        (643     26,114   

Provision for doubtful accounts

     13,201        (313     12,888   

Impairment of intangible and long-lived assets

     1,086        —         1,086   

Loss (gain) on disposal of assets

     (306     6       (300
  

 

 

   

 

 

   

 

 

 

Total operating expenses

     614,141        (6,128     608,013   
  

 

 

   

 

 

   

 

 

 

Operating income

     149,080        (5,182     143,898   

Interest expense

     58,842        —         58,842   

Interest income

     (315     —         (315

Loss on sale of investments

     7,100        —         7,100   
  

 

 

   

 

 

   

 

 

 

Income from continuing operations before income tax expense

     83,453        (5,182     78,271   

Provision for income tax expense

     8,345        (50     8,295   
  

 

 

   

 

 

   

 

 

 

Income from continuing operations

     75,108        (5,132     69,976   
  

 

 

   

 

 

   

 

 

 

Less: Net income attributable to noncontrolling interests from continuing operations

     (92,357     2,512        (89,845
  

 

 

   

 

 

   

 

 

 

Loss attributable to Surgical Care Affiliates from continuing operations

   $ (17,249   $ (2,620   $ (19,869
  

 

 

   

 

 

   

 

 

 

Basic and diluted loss per share attributable to Surgical Care Affiliates:

      

Continuing operations per share attributable to Surgical Care Affiliates

   $ (.57   $ (.09   $ (.66
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding (in thousands)

     30,339        30,339        30,339   
  

 

 

   

 

 

   

 

 

 

 

a) The As reported presentation includes reclassifications totaling $3.7 million within the other revenues and provision for doubtful accounts lines to conform the December 31, 2012 presentation to the presentation at September 30, 2013.
b) These Pro forma adjustments reflect the elimination of the operating results of Fort Worth Endoscopy Center assuming the transaction occurred January 1, 2012.